First, this is the first study demonstrating tumor-specific methylation of BM742401 in CLL as shown by frequent methylation in CLL cell lines and primary CLL samples but not normal controls including normal CD19-sorted peripheral B-cells. This evidence concerns the gene CD19 and neoplasm.